TeleTrader 12-22 Wall Street higher at close ahead of holidays, GDP
GlobeNewswire 12-22 Abbisko Therapeutics’ CSF-1R Inhibitor Pimicotinib Approved by the China NMPA, Addressing the Treatm...
GlobeNewswire 12-19 Evaxion provides update on MSD collaboration - retains global rights to Gonorrhea vaccine candidate ...
GlobeNewswire 12-19 Rezubio Announces $20 Million Series A Financing to Advance the Membrane-Anchored Therapeutics Platf...
GlobeNewswire 12-18 Halper Sadeh LLC Encourages EB, KPLT, WBD, CDTX Shareholders to Contact the Firm to Discuss Their Ri...
GlobeNewswire 12-18 Pyxis Oncology Announces Positive Preliminary Phase 1 Data for Micvotabart Pelidotin (MICVO) in Recu...
GlobeNewswire 12-17 Ascentage Pharma to Present at 44th Annual J.P. Morgan Healthcare Conference
GlobeNewswire 12-16 The M&A Class Action Firm Encourages $hareholders of SMLR, MRSN, CDTX, and RYI to Contact the Firm t...
GlobeNewswire 12-16 Immutep Announces Strong Operational Progress in Global TACTI-004 (KEYNOTE-F91) Phase III and Enrolm...
GlobeNewswire 12-16 Vertero Strengthens Board of Directors with Appointment of Independent Chair R. Scott Greer
GlobeNewswire 12-16 Adagene Announces FDA Fast Track Designation for Muzastotug (ADG126)
GlobeNewswire 12-15 IO Biotech Announces Publication of Five-year Clinical Outcomes of Phase 1/2 Trial in Nature Communi...
GlobeNewswire 12-15 Abeona Therapeutics® Announces Appointment of Mohamad Tabrizi as Chief Business Officer
GlobeNewswire 12-11 Oruka Therapeutics Announces New Board Member and Board Transition
GlobeNewswire 12-10 Halper Sadeh LLC Encourages CADE, MRSN, CDTX Shareholders to Contact the Firm to Discuss Their Right...
GlobeNewswire 12-10 MAIA Takes Aim at a $50B Immunotherapy Market with Breakthrough Telomere-Targeting Approach
GlobeNewswire 12-10 BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Mersana The...
GlobeNewswire 12-10 Medicenna Updates MDNA11 Clinical Trial Results at the ESMO-IO Congress 2025, Further Bolstering its...
GlobeNewswire 12-09 Formycon and Zydus partner for exclusive licensing and supply agreement of FYB206, a biosimilar to K...
GlobeNewswire 12-09 Ligand Hosts 2025 Investor Day and Introduces 2026 Guidance
GlobeNewswire 12-09 ASH 2025 | Updated Data for Ascentage Pharma‘s Olverembatinib in Second-Line CML-CP Showing Encourag...
GlobeNewswire 12-09 ASH 2025 | Ascentage Pharma Presents Four-Year Follow-Up Data from Registrational Phase II Study of ...
GlobeNewswire 12-09 ASH 2025 | Ascentage Pharma Presents First Dataset from Phase III POLARIS-1 Study of Olverembatinib ...
GlobeNewswire 12-08 Halper Sadeh LLC Encourages MRSN, CDTX, RYI Shareholders to Contact the Firm to Discuss Their Rights
GlobeNewswire 12-08 Immutep and Dr. Reddy’s enters into Strategic Collaboration for Commercialisation of an Innovative O...